Comparative effectiveness review of cryoablation for salvage treatment of recurrent prostate cancer following radiotherapy
HAYES, Inc
Record ID 32018000022
English
Authors' recommendations:
Cryoablation of the prostate gland provides a minimally invasive treatment option for the management of localized prostate cancer. The technique uses percutaneously inserted cryoprobes to freeze and thereby destroy cancerous prostate tissue.
Rationale:
The goals of minimally invasive cryoablation for salvage treatment of localized recurrences of prostate cancer after primary radiotherapy (RT) are to use focused cryoablation energy to ablate the entire prostate gland or the cancer-containing part of the gland and achieve complete tumor control to improve survival.
Controversy:
Locally ablative therapies such as cryoablation may have less morbidity compared with other treatment options for localized recurrence of prostate cancer; however, questions remain about the long-term efficacy for local and distant tumor control and survival.
Relevant Questions:
Does salvage cryoablation provide effective local tumor control and acceptable rates of remission and long-term disease-free survival in patients with recurrent prostate cancer following failure of RT? Does salvage cryoablation provide acceptable outcomes with regard to urinary function, prostate symptoms, and sexual function? How does salvage cryoablation compare with other salvage treatment options for recurrent prostate cancer, including radical prostatectomy (RP)? Is salvage cryoablation safe, and what are the related complications? Have definitive patient selection criteria been established for salvage cryoablation treatment for recurrent prostate cancer?
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=69286
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Chronic Disease
- Cryosurgery
- Humans
- Male
- Neoplasm Recurrence, Local
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Salvage Therapy
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.